-
Tirz for Weight LossProduct Name:Tir for Weight Lossread more
CAS No.:2023788-19-2
MF:C225H348N48O68
Form: Powder
Specification:10mg/vial 10vials/box
30mg/vial 10vials/box
60mg/vial... -
SANA PowderProduct Name: SANA Powderread more
CAS No.: 42571-07-3
Form: powder
Function: Lose fat, gain muscle
Appearance: yellow powder
Specification: 5g、10g、50g
MOQ:... -
Retatrutide 2381089-83-2Product Name:Retatrutideread more
Other Name:LY3437943 ,GIP/GLP-1/Glucagon Triple G,Reta
Specification:10mg、20mg、30mg/vial 10vials/box
CAS No.:... -
5 Amino-1 Mq CapsulesProduct name: 5-Amino-1MQ Capsulesread more
Other name: 5-Amino-1-methylquinolinium iodide (NNMT inhibitor)
Specification:60 capsules/bottle
MOQ: 1 bottle
Sample:... -
SLUPP-332 PowderProduct Name:SLUPP-332 Powderread more
Cas number:303760-60-3
Appearance:White powder
Form:powder
Customization:Capsules
Sample:Available
Stock:In... -
Semaglutide 5mgProduct Name: Semaglutideread more
CAS Number: 910463-68-2
Molecular Formula: C187H291N45O59
Molar Mass: 4113.58 g/mol
Purity: ≥98% (HPLC)
Specification: 5mg/vial... -
10mg RetatrutideProduct Name:Retatrutideread more
Other Name:LY3437943 ,GIP/GLP-1/Glucagon Triple G,Reta
Specification:10mg/viaL 10vials/box
CAS No.: 2381089-83-2
Purity:99%
Appearance:... -
Semaglutide for Weight LossProduct name: Semaglutideread more
CAS No.:910463-68-2
Form: Vial Powder
Function: Lose Weight
Appearance: White powder
Specification:5mg/vial 10vials/box... -
5-Amino-1MQ CapsuleProduct Name: 5-Amino-1MQ Capsulesread more
Appearance: Red Capsules
Specification: 99%
CAS NO.: 42464-96-0
Test Methods: COA,HPLC
MOQ: 10 bottles
Package: ...
WebMar 25, 2023 · Mounjaro (Tirzepatide) is the first dual GIP/GLP-1 receptor agonist which means it works on the glucose-dependent insulinotropic polypeptide (GIP) receptors and the glucagon-like...
WebJun 25, 2021 · Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is...
WebSep 3, 2020 · Tirzepatide (LY3298176) is a dual GIP and GLP-1 receptor agonist under development for the treatment of type 2 diabetes mellitus (T2DM), obesity, and nonalcoholic steatohepatitis....
WebJun 23, 2023 · Tirzepatide (or matching placebo) was initiated at 2·5 mg once weekly and increased by 2·5 mg every 4 weeks until the target dose was reached (ie, 10 mg or 15 mg at 12 weeks or 20...
WebMay 1, 2023 · Tirzepatide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. Tirzapatide is a glucagon-like peptide...
Web1 day ago · Tirzepatide, an injectable drug, targets two obesity-related hormones, glucagon-like peptide 1, or GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP; orforglipron targets...
